{"id":1257,"date":"2026-04-01T08:00:08","date_gmt":"2026-04-01T06:00:08","guid":{"rendered":"https:\/\/www.tagpartners.fr\/?p=1257"},"modified":"2026-03-31T10:03:40","modified_gmt":"2026-03-31T08:03:40","slug":"oury-medical-acquires-cefimeca","status":"publish","type":"post","link":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/","title":{"rendered":"OURY MEDICAL acquires CEFIMECA"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]<strong>ISALT and TAG Partners invest in Oury Medical to finance the acquisition of C\u00e9fim\u00e9ca<\/strong><\/p>\n<p><strong><u>Paris, April 01, 2026 <\/u><\/strong><strong>\u2013 The Strategic Transitions Fund (FST), managed by ISALT, and TAG Partners are leading the new funding round of Oury Medical, a French industrial group specializing in orthopedic and spinal medical instrumentation, in connection with its acquisition of C\u00e9fim\u00e9ca, a French specialist in the field. FST and TAG Partners are investing alongside several family offices and private investors to finance this transaction.<\/strong><\/p>\n<p>This investment will enable Oury Medical to:<\/p>\n<ul>\n<li><strong>Finance the acquisition of C\u00e9fim\u00e9ca<\/strong> and strengthen its <strong>industrial capabilities<\/strong>;<\/li>\n<li>Consolidate its balance sheet to <strong>support technological and production investments<\/strong>;<\/li>\n<li>Continue its <strong>build-up strategy<\/strong> and establish itself as a <strong>leading player in medical instrumentation<\/strong> in France and internationally.<\/li>\n<\/ul>\n<table>\n<tbody>\n<tr>\n<td width=\"599\"><strong>\u00a0Laurent Piccoli, Partner at ISALT, stated:<\/strong><\/p>\n<p><em>\u201cThe Strategic Transitions Fund is proud to support Oury Medical in the acquisition of C\u00e9fim\u00e9ca, alongside TAG Partners, whose team has implemented a highly effective and value-creating build-up strategy for the company over recent years. Oury Medical is one of the very few French players capable of manufacturing orthopedic and spinal instruments and implant components on behalf of global orthopedic leaders. This investment fully aligns with our mission: to support innovative companies in their acceleration phase and contribute to the emergence of the next generation of French industrial champions, in close collaboration with ambitious and committed management teams.\u201d<\/em><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Georges-Alexandre Ancenys, Thierry Manceau and Andr\u00e9 Wagner, Founding Partners of TAG Partners, stated:<\/strong><\/p>\n<p><em>\u201cWe warmly thank ISALT and all the investors who have chosen to co-invest alongside TAG Partners in Oury Medical. Their trust and financial commitment enable Oury Medical to reach a decisive milestone by completing the acquisition of C\u00e9fim\u00e9ca and to continue, with ambition, the build-up strategy initiated three years ago, aimed at becoming a leading player in medical instrumentation. We are convinced that this new shareholder structure represents a major asset for the Group\u2019s growth and development.\u201d<\/em><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>S\u00e9bastien Meunier, CEO of Oury Medical Group, stated:<\/strong><\/p>\n<p><em>\u201cI would like to thank TAG Partners for the trust and support provided over the past three years to the entire management team. I would also like to thank ISALT and the new investors who, through this new funding round, enable us to continue our consolidation strategy. With the acquisition of C\u00e9fim\u00e9ca, we are integrating complementary capabilities in instrumentation and selected implants, strengthening the value we bring to our clients, while remaining focused on our industrial DNA.\u201d<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong><u>A rapidly expanding group in a high-precision medical sector<br \/>\n<\/u><\/strong><\/li>\n<li>In response to the growing demand for integrated solutions from orthopedic and spinal players, Oury Medical has been building, since TAG Partners\u2019 acquisition of Oury-Guy\u00e9 three years ago, <strong>a leading French industrial platform in orthopedic medical instrumentation<\/strong>. The strategy is based on targeted acquisitions aimed at combining complementary manufacturing expertise to serve both French and international clients. The acquisition of C\u00e9fim\u00e9ca represents the fifth build-up transaction completed since the launch of this platform strategy.<\/li>\n<li>C\u00e9fim\u00e9ca brings <strong>recognized expertise in orthopedic and spinal instruments<\/strong>, complemented by a selective range of implants for which its precision manufacturing capabilities are particularly well regarded. This combination strengthens Oury Medical\u2019s positioning as a partner offering turnkey solutions to its clients. <strong>With five production sites in France and more than 200 employees<\/strong>, Oury Medical now has the industrial scale required <strong>to consolidate its position in the major global orthopedic and spinal surgery markets.<\/strong><\/li>\n<\/ul>\n<p><strong><u>Advisors and contributors<\/u><\/strong><\/p>\n<p><strong>Investors:<\/strong><\/p>\n<ul>\n<li>ISALT (Fonds Strat\u00e9gique des Transitions) : Laurent Piccoli, Maxime Amiant, Sarah Loertscher<\/li>\n<li>TAG Partners : Georges-Alexandre Ancenys, Thierry Manceau, Andr\u00e9 Wagner<\/li>\n<\/ul>\n<p><strong>Advisors to the Buyer (Oury Medical \/ TAG Partners \/ ISALT):<\/strong><\/p>\n<ul>\n<li>Financial advisors: Potomac Transactions (S\u00e9bastien Drouot, Thomas Meleard, Florian Leroux); Eiger Corporate Finance (Pascal Dormont, Pierre-Louis Reynaud)<\/li>\n<li>Legal advisors: Hogan Lovells (Christophe-Marc Juvanon, Sophie Tricot); Gide Loyrette Nouel (Paul Jourdan-Nayrac, Julien Negroni)<\/li>\n<li>Tax advisor: Gide Loyrette Nouel (Alexandre Bochu, Manon Lorthiois)<\/li>\n<li>Financial due diligence: Oderis (Julien Latrubesse, Thyl Bourgeois); KPMG (Bertrand Thouvenel, Martin Dufort)<\/li>\n<li>Strategic due diligence: Avicenne (Ali Madani, Jean-Philippe Salvat)<\/li>\n<li>Legal, tax and social due diligence: Forvis Mazars (J\u00e9r\u00f4me Gertler, Iosif Cozea)<\/li>\n<\/ul>\n<p><strong>Advisors to the Seller (C\u00e9fim\u00e9ca):<\/strong><\/p>\n<ul>\n<li>Financial advisor: CIC Conseil (Christophe Kamel, Pierre-Axel Diederichs)<\/li>\n<li>Legal advisor: Viricel et Conseils (S\u00e9verin Viriciel, Dimitri Chailonick)<\/li>\n<\/ul>\n<p><strong>About ISALT<\/strong><\/p>\n<p>ISALT is an independent asset management company (AMF approval no. GP-19000045) specializing in long-term equity investments in French companies. Since its creation in 2020, ISALT has been developing a sustainable investment platform, providing stable and constructive capital to French companies operating in key sectors of the economy. ISALT implements an investment strategy focused on acquiring significant long-term stakes while playing an active role in corporate governance. The firm manages the Strategic Participations Fund (FSP) and the Strategic Transitions Fund (FST). For more information: <a href=\"https:\/\/www.isalt-gestion.com\/\">https:\/\/www.isalt-gestion.com\/<\/a><\/p>\n<p><strong>About the Strategic Transitions Fund (FST), managed by ISALT<\/strong><\/p>\n<p>The Strategic Transitions Fund (FST) is dedicated to innovative SMEs and mid-sized companies. Launched in March 2023 with the support of Caisse des D\u00e9p\u00f4ts et Consignations (CDC) and the Strategic Participations Fund (FSP)\u2014managed by ISALT since 2013\u2014the FST was established as a limited partnership (SLP). Its objective is to support the industrial scaling of innovative French SMEs and mid-sized companies, taking into account the future needs of society. Targeting companies with advanced and robust technologies, the FST aims to finance their industrial ramp-up by supporting increased production capacity, while ensuring that environmental, technological and social transitions remain at the core of their strategy. The fund is classified as Article 8 under SFDR regulations and benefits from the support of the European Union under the InvestEU Fund.<\/p>\n<p><strong>About TAG Partners<\/strong><\/p>\n<p>TAG Partners is an independent investment firm (Independent Sponsor) co-founded and led by Georges-Alexandre Ancenys, Thierry Manceau and Andr\u00e9 Wagner. Its mission is to support high-potential French SMEs in their transmission, transformation and growth.<\/p>\n<p>The founding partners combine CEO and investor experience to lead value creation and transition projects across three priority areas:<\/p>\n<ul>\n<li>Operational transformation \u2014 strengthening teams and reorienting the organization towards a new phase of development<\/li>\n<li>Strategic build-ups \u2014 reinforcing positioning within the value chain and expanding the product offering<\/li>\n<li>Commercial development \u2014 activating local and international growth drivers<\/li>\n<\/ul>\n<p>TAG Partners operates under an Independent Sponsor model, bringing together for each investment a pool of co-investors\u2014including entrepreneurs, family offices and sector experts\u2014to foster a dynamic of exchange and co-construction with the management teams of the companies it supports.<\/p>\n<p><strong>About Oury Medical<\/strong><\/p>\n<p>Oury Medical is an independent French group specializing in the manufacturing of surgical instruments for orthopedics and spine. With more than 100 years of expertise, the Group supports its clients from design to the production of both standard and custom instruments.<\/p>\n<p>Oury Medical operates three production sites in France, in Nogent, Chaumont and Grenoble, and offers a \u201cone-stop solution\u201d approach covering design, manufacturing, kitting and re-kitting of complete instrument trays, as well as maintenance and lifecycle management. The Group is led by an experienced management team serving clients worldwide.[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>The Strategic Transitions Fund (FST), managed by ISALT, and TAG Partners are leading the new funding round of Oury Medical, a French industrial group specializing in orthopedic and spinal medical instrumentation, in connection with its acquisition of C\u00e9fim\u00e9ca, a French specialist in the field&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1256,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-1257","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-non-classifiee"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>OURY MEDICAL acquires CEFIMECA - TAG Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OURY MEDICAL acquires CEFIMECA - TAG Partners\" \/>\n<meta property=\"og:description\" content=\"The Strategic Transitions Fund (FST), managed by ISALT, and TAG Partners are leading the new funding round of Oury Medical, a French industrial group specializing in orthopedic and spinal medical instrumentation, in connection with its acquisition of C\u00e9fim\u00e9ca, a French specialist in the field...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\" \/>\n<meta property=\"og:site_name\" content=\"TAG Partners\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T06:00:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T08:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1037\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"zeugma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"zeugma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\"},\"author\":{\"name\":\"zeugma\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/b186f8a547f506fa4d6aa46d5c3b1f05\"},\"headline\":\"OURY MEDICAL acquires CEFIMECA\",\"datePublished\":\"2026-04-01T06:00:08+00:00\",\"dateModified\":\"2026-03-31T08:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\"},\"wordCount\":1328,\"publisher\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\",\"url\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\",\"name\":\"OURY MEDICAL acquires CEFIMECA - TAG Partners\",\"isPartOf\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg\",\"datePublished\":\"2026-04-01T06:00:08+00:00\",\"dateModified\":\"2026-03-31T08:03:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage\",\"url\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg\",\"contentUrl\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg\",\"width\":1920,\"height\":1037},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.tagpartners.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OURY MEDICAL acquires CEFIMECA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#website\",\"url\":\"https:\/\/www.tagpartners.fr\/en\/\",\"name\":\"TAG Partners\",\"description\":\"Soci\u00e9t\u00e9 d\u2019investissement PME fran\u00e7aises\",\"publisher\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.tagpartners.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#organization\",\"name\":\"TAG Partners\",\"url\":\"https:\/\/www.tagpartners.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2024\/09\/Capture-decran-2024-09-06-a-15.30.05.png\",\"contentUrl\":\"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2024\/09\/Capture-decran-2024-09-06-a-15.30.05.png\",\"width\":383,\"height\":78,\"caption\":\"TAG Partners\"},\"image\":{\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/b186f8a547f506fa4d6aa46d5c3b1f05\",\"name\":\"zeugma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bfe7139287444db8ba1ba420eaaddeca363463f419d1309b62bcbfaf3404cd48?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bfe7139287444db8ba1ba420eaaddeca363463f419d1309b62bcbfaf3404cd48?s=96&d=mm&r=g\",\"caption\":\"zeugma\"},\"sameAs\":[\"https:\/\/tag.zwa.fr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OURY MEDICAL acquires CEFIMECA - TAG Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/","og_locale":"en_US","og_type":"article","og_title":"OURY MEDICAL acquires CEFIMECA - TAG Partners","og_description":"The Strategic Transitions Fund (FST), managed by ISALT, and TAG Partners are leading the new funding round of Oury Medical, a French industrial group specializing in orthopedic and spinal medical instrumentation, in connection with its acquisition of C\u00e9fim\u00e9ca, a French specialist in the field...","og_url":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/","og_site_name":"TAG Partners","article_published_time":"2026-04-01T06:00:08+00:00","article_modified_time":"2026-03-31T08:03:40+00:00","og_image":[{"width":1920,"height":1037,"url":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg","type":"image\/jpeg"}],"author":"zeugma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"zeugma","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#article","isPartOf":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/"},"author":{"name":"zeugma","@id":"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/b186f8a547f506fa4d6aa46d5c3b1f05"},"headline":"OURY MEDICAL acquires CEFIMECA","datePublished":"2026-04-01T06:00:08+00:00","dateModified":"2026-03-31T08:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/"},"wordCount":1328,"publisher":{"@id":"https:\/\/www.tagpartners.fr\/en\/#organization"},"image":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/","url":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/","name":"OURY MEDICAL acquires CEFIMECA - TAG Partners","isPartOf":{"@id":"https:\/\/www.tagpartners.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage"},"image":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg","datePublished":"2026-04-01T06:00:08+00:00","dateModified":"2026-03-31T08:03:40+00:00","breadcrumb":{"@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#primaryimage","url":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg","contentUrl":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2026\/03\/tag-partners-4.jpg","width":1920,"height":1037},{"@type":"BreadcrumbList","@id":"https:\/\/www.tagpartners.fr\/en\/2026\/04\/01\/oury-medical-acquires-cefimeca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.tagpartners.fr\/en\/"},{"@type":"ListItem","position":2,"name":"OURY MEDICAL acquires CEFIMECA"}]},{"@type":"WebSite","@id":"https:\/\/www.tagpartners.fr\/en\/#website","url":"https:\/\/www.tagpartners.fr\/en\/","name":"TAG Partners","description":"Soci\u00e9t\u00e9 d\u2019investissement PME fran\u00e7aises","publisher":{"@id":"https:\/\/www.tagpartners.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tagpartners.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.tagpartners.fr\/en\/#organization","name":"TAG Partners","url":"https:\/\/www.tagpartners.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.tagpartners.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2024\/09\/Capture-decran-2024-09-06-a-15.30.05.png","contentUrl":"https:\/\/www.tagpartners.fr\/wp-content\/uploads\/2024\/09\/Capture-decran-2024-09-06-a-15.30.05.png","width":383,"height":78,"caption":"TAG Partners"},"image":{"@id":"https:\/\/www.tagpartners.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/b186f8a547f506fa4d6aa46d5c3b1f05","name":"zeugma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.tagpartners.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bfe7139287444db8ba1ba420eaaddeca363463f419d1309b62bcbfaf3404cd48?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfe7139287444db8ba1ba420eaaddeca363463f419d1309b62bcbfaf3404cd48?s=96&d=mm&r=g","caption":"zeugma"},"sameAs":["https:\/\/tag.zwa.fr"]}]}},"_links":{"self":[{"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/posts\/1257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/comments?post=1257"}],"version-history":[{"count":4,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/posts\/1257\/revisions"}],"predecessor-version":[{"id":1265,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/posts\/1257\/revisions\/1265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/media\/1256"}],"wp:attachment":[{"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/media?parent=1257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/categories?post=1257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tagpartners.fr\/en\/wp-json\/wp\/v2\/tags?post=1257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}